Principal Financial Group Inc. Has $280.65 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Principal Financial Group Inc. reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 13.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 601,132 shares of the company's stock after selling 91,279 shares during the period. Principal Financial Group Inc. owned approximately 0.26% of HCA Healthcare worth $280,645,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth about $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare in the 4th quarter worth about $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare in the 4th quarter worth about $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare in the 3rd quarter valued at $33,000. Finally, Aventura Private Wealth LLC acquired a new position in HCA Healthcare in the 4th quarter valued at $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares of the company's stock, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company's stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 13,714 shares of company stock valued at $7,050,460. Company insiders own 1.50% of the company's stock.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. JPMorgan Chase & Co. lifted their price objective on HCA Healthcare from $420.00 to $535.00 and gave the company a "neutral" rating in a report on Friday, February 20th. KeyCorp dropped their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. Wall Street Zen cut shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. The Goldman Sachs Group boosted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a report on Wednesday, January 28th. Finally, UBS Group boosted their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a "buy" rating in a report on Monday, February 23rd. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $517.82.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $428.94 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The firm has a 50 day moving average price of $495.58 and a two-hundred day moving average price of $486.47. The stock has a market cap of $95.16 billion, a P/E ratio of 14.75, a price-to-earnings-growth ratio of 1.36 and a beta of 1.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter last year, the company posted $6.45 earnings per share. The company's revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts predict that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.